Status:
UNKNOWN
Necrotizing Enterocolitis in Fetuses With Intrauterine Growth Restriction
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Necrotizing Enterocolitis
Eligibility:
All Genders
Brief Summary
Necrotizing enterocolitis is the most common gastroenterological emergency in neonatology. Its mortality is high, ranging from 15 to 30%. Prematurity is the main risk factor for necrotizing enterocoli...
Eligibility Criteria
Inclusion
- All birth between 24 + 0 weeks of amenorrhea and 36 + 6 weeks of amenorrhea
- with isolated intrauterine growth restriction at the maternity ward of the hospital Femme-Mère-Enfant
- from 1st of january 2011 to 31 december 2016.
- Inclusion Criteria for control group:
- All birth between 24 + 0 weeks of amenorrhea and 36 + 6 weeks of amenorrhea
- without isolated intrauterine growth restriction at the maternity ward of the hospital Femme-Mère-Enfant
- from 1st of january 2011 to 31 december 2016.
Exclusion
- Infants born out of the hospital and secondarily hospitalized in our department
- unaccompanied pregnancies
- multiple pregnancies
- children with malformations or genetic abnormalities,
- medical termination of pregnancy
- fetal deaths in utero
Key Trial Info
Start Date :
September 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2019
Estimated Enrollment :
378 Patients enrolled
Trial Details
Trial ID
NCT03869827
Start Date
September 1 2018
End Date
April 1 2019
Last Update
March 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Femme Mère Enfant
Bron, France